Oxaliplatin Kabi

Oxaliplatin, the active ingredient in Oxaliplatin Kabi, is a platinum‑based chemotherapy agent presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer, often in combination with other chemotherapeutic agents, and is administered to adult patients.

GNH USA supplies Oxaliplatin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oxaliplatin Kabi is a platinum‑based chemotherapeutic that acts on rapidly ​growing cancer cells, particularly within the gastrointestinal tract.

- Colorectal cancer: Enhances survival‑based ​prolongation ​of progression‑free survival when combined ​with ​5‑FU/LV regimens. - Gastric cancer: Used ​as ​part ​of ​multimodal ​treatment ​protocol ​for ​advanced ​disease ​and ​palli ​care. - Pancreatic ​pancre ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​pan ​​

Oxaliplin ​     …  

...